Design of a depot formulation for disulfiram

Design of a depot formulation for disulfiram

A dissertation submitted to the Faculty of Health Sciences, University of the Witwatersrand, in fulfilment of the requirements for the degree of Master of Pharmacy Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, South Africa Johannesburg, 2016...

Full description

Bibliographic Details
Main Author:	Mia, Fatema
Format:	Others
Language:	en
Published:	2017
Online Access:	http://hdl.handle.net/10539/23145

Similar Items

Disulfiram reaction
by: Banjac Nada, et al.
Published: (2019-01-01)

Disulfiram-induced polyneurophaty
by: Vujisić Slavica, et al.
Published: (2012-01-01)

Disulfiram-induced dystonia
by: Vishwanatha Sham Alamela, et al.
Published: (2016-01-01)

Catatonia induced by disulfiram
by: HK Goswami, et al.
Published: (2015-07-01)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
by: Vinodh Kannappan, et al.
Published: (2021-09-01)

Choque cardiogênico por dissulfiram Shockcardiogénico por disulfiram Cardiogenic shock caused by disulfiram
by: Ana Jerónimo, et al.
Published: (2009-03-01)

Disulfiram-like reaction with ornidazole
by: Sharma V, et al.
Published: (2009-01-01)

ROLE OF LEUPRORELINE ACETATE DEPOT (LUCRIN DEPOT®) FORMULATIONS IN THE TREATMENT OF PROSTATE CANCER
by: M. I. Volkova
Published: (2014-07-01)

ROLE OF LEUPRORELINE ACETATE DEPOT (LUCRIN DEPOT®) FORMULATIONS IN THE TREATMENT OF PROSTATE CANCER
by: M. I. Volkova
Published: (2014-07-01)

Antibacterial Effects of Disulfiram in Helicobacter pylori
by: Kobatake T, et al.
Published: (2021-05-01)

Disulfiram-Induced Acute Liver Injury
by: Lucas Ramer, et al.
Published: (2020-01-01)

A Case of Psychosis in Disulfiram Treatment for Alcoholism
by: Raquel Calvão de Melo, et al.
Published: (2014-01-01)

Amyloid as a depot for the formulation of long-acting drugs.
by: Samir K Maji, et al.
Published: (2008-02-01)

Expediting Disulfiram Assays through a Systematic Analytical Quality by Design Approach
by: João Basso, et al.
Published: (2021-07-01)

Maniac psychosis and erythematous dermatitis induced by disulfiram
by: Naveen D Kumar
Published: (2017-01-01)

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
by: Denisa Weiser Drozdkova, et al.
Published: (2021-06-01)

New Disulfiram Derivatives as MAGL-Selective Inhibitors
by: Ziad Omran
Published: (2021-05-01)

Disulfiram Induces Cytotoxicity in NG108-15 Cells
by: HSU, TSENG-YU, et al.
Published: (2017)

Structure of inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin
by: V. S. Tyukova, et al.
Published: (2015-10-01)

The Evolving Role of Disulfiram in Radiobiology and the Treatment of Breast Cancer
by: Wang R, et al.
Published: (2020-10-01)

Development of combined encapsulated drug on the basis of naltrexone and disulfiram
by: Володимир Павлович Новіков, et al.
Published: (2015-04-01)

Oculogyric Crisis Associated with Disulfiram-Induced Pallidonigral Lesion
by: Jae Hyeok Lee, et al.
Published: (2009-05-01)

Disulfiram-alcohol reaction in 49 year old patient
by: Krystian Lech Ciechański, et al.
Published: (2018-09-01)

Overview of Antabuse® (Disulfiram) in Radiation and Cancer Biology
by: Jia Y, et al.
Published: (2021-05-01)

Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
by: Ranković Anica, et al.
Published: (2018-03-01)

Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.
by: Marilyn D Skinner, et al.
Published: (2014-01-01)

Interaction between disulfiram and betel chewing: A case series
by: A. Ellepola, et al.
Published: (2016-06-01)

Injectable Lipid-Based Depot Formulations: Where Do We Stand?
by: Lisa Rahnfeld, et al.
Published: (2020-06-01)

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
by: Rajni Sethi, et al.
Published: (2009-06-01)

Malignant catatonia and neuroleptic malignant syndrome in relation to disulfiram overdose
by: Kiran K Kumar, et al.
Published: (2016-01-01)

The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells
by: Narges Rezaei, et al.
Published: (2020-10-01)

Disulfiram-induced toxic pustuloderma (Acute Generalized Exanthematous Pustulosis)
by: Prashant B Jadhav
Published: (2016-01-01)

Disulfiram thermosensitive in-situ gel based on solid dispersion for cataract
by: Chunjuan Zhang, et al.
Published: (2018-11-01)

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
by: Silvia Schmidtova, et al.
Published: (2019-08-01)

Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis
by: Hanna Bonnekoh, et al.
Published: (2021-07-01)

A fluorescence-based assay for octreotide in kinetic release from depot formulations
by: Luiz Henrique Guerreiro, et al.
Published: (2012-01-01)

Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.
by: Kristof Segher, et al.
Published: (2020-01-01)

Disulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agent.
by: Hua Ying, et al.
Published: (2015-01-01)

Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
by: Raphael Mietzner, et al.
Published: (2020-07-01)

Co-treatment with disulfiram and glycyrrhizic acid suppresses the inflammatory response of chondrocytes
by: Chao Li, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_sh8nlt6mk2jkkf9m1ke5egg3nt